TCR repertoire analysis on CD4+ T cells from tumor, blood, and lymph nodes of five breast cancer patients revealed that tumor-infiltrating Tregs are most similar to naïve CD4+ T cells from tumor and blood, suggesting intratumoral conversion. This evidence concerns the gene CD4 and breast cancer.